Form 4: IRADIMED Director Sells 3,000 Shares

IRADIMED Corp. Director and 10% Owner James B. Hawkins sold 3,000 shares of common stock for a weighted average price of $96.6125 per share on December 9, 2025.

Summary

• James B. Hawkins, a Director and 10% Owner of IRADIMED Corp. (IRMD), reported a sale of common stock.
• The transaction involved the disposition of 3,000 shares of common stock.
• The sale occurred on December 9, 2025, at a weighted average price of $96.6125 per share.
• The transaction was executed in multiple trades with prices ranging from $96.50 to $97.07.
• Following this transaction, James B. Hawkins directly beneficially owns 28,742 shares of IRADIMED Corp. common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 5

Explanation: The filing is a standard insider transaction disclosure (Form 4) and does not inherently convey positive or negative sentiment regarding the company's operational performance or future prospects. It reports a director's sale of shares.

Future Outlook

This Form 4 filing is a disclosure of an insider transaction and does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing reports a routine insider transaction and does not provide information directly related to broader industry trends or competitive landscape. It reflects an individual director's trading activity within the company's stock.

Related Party Transactions

• Sale of 3,000 shares of common stock by James B. Hawkins, a Director and 10% Owner of IRADIMED Corp., at a weighted average price of $96.6125 per share.

Stakeholder Impact

• Shareholders may interpret the sale of shares by a Director and 10% Owner as a signal regarding management's perception of the company's valuation or future prospects, potentially influencing investor sentiment.

Key Dates

Keywords

IRADIMED, IRMD, Form 4, insider trading, stock sale, director, 10% owner, James B. Hawkins, beneficial ownership, Rule 10b5-1